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a b s t r a c t
Protein degradation constitutes a major cellular function that is responsible for maintenance of the
normal cellular physiology either through the degradation of normal proteins or through the elimination
of damaged proteins. The Ubiquitin–Proteasome System (UPS)1 is one of the main proteolytic systems
that orchestrate protein degradation. Given that up- and down- regulation of the UPS system has
been shown to occur in various normal (such as ageing) and pathological (such as neurodegenerative
diseases) processes, the exogenous modulation of the UPS function and activity holds promise of
(a) developing new therapeutic interventions against various diseases and (b) establishing strategies to
maintain cellular homeostasis. Since the proteasome genes are evolutionarily conserved, their role can be
dissected in simple model organisms, such as the nematode, Caenorhabditis elegans. In this review, we
survey ﬁndings on the redox regulation of the UPS in C. elegans showing that the nematode is an
instrumental tool in the identiﬁcation of major players in the UPS pathway. Moreover, we speciﬁcally
discuss UPS-related genes that have been modulated in the nematode and in human cells and have
resulted in similar effects thus further exhibiting the value of this model in the study of the UPS.
& 2014 The Authors. Published by Elsevier B.V. All rights reserved.
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Introduction
Proteolysis
Proteolysis refers to the breakdown of proteins into smaller
polypeptides or amino acids. In general, this occurs through the
hydrolysis of peptide bonds, and this is most commonly achieved
by cellular enzymes called proteases (enzyme-mediated degrada-
tion), but may also occur through intramolecular digestion, as well
as through non-enzymatic routes such as the action of mineral
acids and heat.
Proteolysis has various roles on the cellular maintenance. It
occurs in order to provide amino acids to the cells [153], to activate
post-translationally certain proteins [22], to regulate physiological
cellular processes (e.g. cell cycle regulation, apoptosis etc) and to
prevent the accumulation of abnormal or misfolded proteins [26].
The two main mechanisms of cellular proteolysis that play a key
role in cellular homeostasis are the lysosome-mediated intracel-
lular protein degradation and the proteasome-mediated protein
degradation.
Lysosomes are single or double membrane organelles that
enclose acidic hydrolases with multiple speciﬁcities, such as
peptidases, lipases and nucleases for the degradation of various
biological molecules. One can distinguish different forms of
autophagy mainly based on the mechanism for the delivery of
cargo to the lysosomes. The main forms are the so called
macroautophagy, microautophagy and chaperone-mediated
autophagy. In general, autophagy is a bulk degradation process
implicated in the clearance of long-lived proteins and organelles
but more selective forms of autophagy have also been described
for both macro- and micro-autophagy. Macroautophagy is the
main pathway, responsible for the elimination of damaged cell
organelles or unused proteins [96]. This involves the formation
of a double-layered membrane around the organelle known as
an autophagosome [16]. The autophagosome travels through the
cytoplasm of the cell to get fused with a lysosome and to carry
on to the endosomal pathways [110]. Within the lysosome, the
contents of the autophagosome are degraded via acidic lysoso-
mal hydrolases [60]. In microautophagy, the cargo is engulfed by
single-membraned vesicles originated by invagination of the
lysosomal membrane that then pinches off inside the lumen
where it is rapidly degraded [112]. Finally, chaperone-mediated
autophagy (CMA) is a selective protein degradation pathway by
which soluble cytosolic proteins bearing in their amino acid
sequences a common targeting motif (KFERQ-like pentapeptide
sequence) are recognized by a chaperone complex (hsc70-
containing complex) which targets them to lysosomes for
degradation [105]. These proteins have to be bound to the
lysosome-associated membrane protein type 2A (LAMP-2A), a
CMA receptor at the lysosomal membrane, in order to be
translocated into the lysosomal lumen and to get degraded by
the lysosomal proteases.
Proteasome-mediated proteolysis refers to a selective cellular
process that results in the speciﬁc degradation of either un-needed
(but normal) or damaged/misfolded proteins. Proteasomes are
part of a major mechanism by which cells regulate the concentra-
tion of particular proteins and degrade misfolded proteins, the
so called Ubiquitin–Proteasome System (UPS). Proteins, that
need to be degraded, are tagged with a series of a small protein
called ubiquitin. The result is a poly-ubiquitin chain on the pro-
tein to be degraded that is recognized by the proteasome, allow-
ing it to degrade the tagged protein [102]. This review
will focus on the proteasome-mediated proteolysis on a model
organism for ageing studies, namely the nematode Caenorhabditis
elegans.
Caenorhabditis elegans
The nematode C. elegans is a roundworm. The roundworms,
a phylum of smooth-skinned, unsegmented worms with a long
cylindrical body shape, include free-living and parasitic forms
both aquatic and terrestrial. C. elegans is a non-hazardous, non-
infectious, non-pathogenic, non-parasitic organism. It is small,
growing to about 1 mm in length, and lives in the soil, where
it survives by feeding on microbes, primarily bacteria [183].
C. elegans genome, which is completely sequenced (approximately
100 million base pairs long), consists of ﬁve pairs of autosomes
(I, II, III, IV and V) and one pair of sex chromosomes (X), so as of
mitochondrial genome. C. elegans has two sexes, hermaphrodites
and males. Almost all individuals are hermaphrodites, with males
comprising just 0.05% on average of the total population. Sex in C.
elegans is based on an X0 sex-determination system. Hermaphro-
dite C. elegans have a matched pair of sex chromosomes (XX) and
the rare males have only one sex chromosome (X0). When self-
inseminated, the wild-type wormwill lay approximately 300 eggs.
When inseminated by a male, the number of progeny can
exceed 1000.
The basic anatomy of C. elegans includes a mouth, a pharynx, an
intestine, a gonad (two bilaterally symmetric, U-shaped gonad
arms that are connected to a central uterus through spermatheca)
and a collagenous cuticle. The four bands of muscles that run the
length of the body are connected to a neuronal system, that is
thoroughly mapped, that allows the muscles to move the animal0s
body only in the dorsal and ventral direction.
The hermaphrodite is considered to be a specialized form of
self-fertile female because the soma is female but its germ line
produces male gametes ﬁrstly and then conducts the laying of
eggs. Eggs are deposited externally through the uterus following
internal fertilization. After hatching, juveniles pass through four
stages (larval stages: L1–L4). When the population of the culture is
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crowded or under caloric restriction conditions, C. elegans can
enter an alternative larval stage (L3 stage) called the dauer state.
Dauer larvae are stress-resistant and do not age. At 20 1C, the
laboratory strain of C. elegans has an average lifespan of approxi-
mately 3 weeks and a generation time of approximately 4 days.
In the three last decades, multiple studies have focused on the
regulation of certain signaling pathways and cellular processes,
which have been conserved through evolution in humans, such us
ageing, proteolysis and response to oxidative stress. C. elegans has
been shown to be a valuable model in studying these processes




20S proteasomes are large protein complexes of approximately
700 kDa inside all eukaryotes and archaea, as well as in some
bacteria. The main catalytic function of the proteasome is to
degrade normal or damaged proteins by proteolysis, a chemical
reaction that breaks peptide bonds. This degradation process
yields peptides of about seven to eight amino acids long, which
can then be further degraded by various peptidases into amino
acids and used in synthesis of new proteins. In eukaryotes,
oxidized proteins or proteins with attached polyubiquitin chains
are bound by the proteasome and get degraded.
The eukaryotic 20S proteasome, which is the main particle
of the proteasomal mechanism also known as the 20S proteasome
core, is a large cylindrical structure containing four stacked
homologous rings, 2α (consisted by α-type subunits) and 2β
(consisted by β-type subunits), around a central pore. Each ring
is composed of seven different protein subunits (molecular mass
between 20 and 30 kDa) thus giving rise to the ﬁnal 20S structure,
α17β17β17α17. The inner two rings are each made of seven
different β-type subunits and three of those namely, β1, β2 and β5
contain three proteolytic active sites; chymotrypsin-like, trypsin-
like and caspase-like activities (see below; [72]). These sites are
located on the interior surface of the rings, so that the target
protein must enter the central pore before it is degraded. The
outer two rings maintain a “gate” through which proteins enter
the cylinder. The α-type subunits are controlled by binding to
“cap” structures or regulatory particles that recognize polyubiqui-
tin tags attached to candidate protein substrates and initiate the
degradation process. Table 1 summarizes the orthologues of the
20S human proteasome subunits in C. elegans.
α-Type subunits in C. elegans. The α-type proteasomal subunits
are arranged in the two outer rings of the core proteasome and
possess structural and regulatory roles. They compose the gate of
the 20S core proteasome that regulates the access of the substrate
towards the pore, through allosteric interactions. In C. elegans all
seven α-type subunits (pas-1 to pas-7) have been mapped [24],
and all of them have a statistical signiﬁcant homology with the
ones found in Homo sapiens and Saccharomyces cerevisiae.
The pas-1 gene encodes for a type-6 alpha subunit of the 20S
core particle in humans and is required for embryonic develop-
ment. By homology, it is predicted to comprise the outer rings of
the proteasome and to play a role in selective degradation of
ubiquitinated proteins during development. In vitro, PAS-1 inter-
acts with VET-1, a coiled-coil domain-containing protein expressed
in the early embryo and ATN-1, an alpha-actinin, in addition to
other members of the proteasome [24]. The pas-2 gene encodes for
a proteasome subunit with high similarity to human proteasome
α2 subunit [8] and is revealed to be an orthologue of the yeast
protein Sec18, member of the AAA ATPase family [24]. The pas-3
gene encodes for a type-4 alpha subunit in humans that affects
embryonic viability, growth, fertility, and locomotion [38] and
resembles to the human TGF-β receptor associated protein-1 [24].
The pas-4 gene encodes for a type-7 alpha subunit of the 20S core
in humans. Loss of pas-4 activity via RNAi results in a wide variety
of defects including embryonic and larval lethality, sterility,
abnormal locomotion, slow growth, and abnormal transgene
expression and subcellular localization [38,154]. Furthermore, loss
of PAS-4 activity also results in activation of SKN-1, a transcription
factor required in adult worms for the acute response to oxidative
stress that is absolutely necessary for embryonic development
[75]. The pas-5 gene encodes for a type-5 alpha subunit of the 20S
core in humans. Loss of pas-5 activity via RNAi has the same
results as loss of pas-4 [38,154,141,142,166]. The pas-6 gene
encodes for a type-1 alpha subunit in humans. PAS-6 is required
for embryonic, larval, and germline development. In vitro, PAS-6
interacts with BRP-1, a glutamine/asparagine (Q/N)-rich domain-
containing protein conserved amongst nematodes, and with other
proteasome subunits [28,185]. The pas-7 gene encodes for a type-3
alpha subunit in humans. Its loss via RNAi results in several defects
including embryonic and larval lethality, sterility, and abnormal
meiotic progression [167,141,142,34,166]. The α3 subunit plays a
central role in the mammalian 20S proteasome since it regulates
the stabilization of the gate and the allosteric interactions between
α2, α3 and α4 by altering the conformation of its N-terminal end
[49]; PAS-7 is its orthologue in C. elegans.
β-Type subunits in C. elegans. The β-type proteasomal subunits
enclose the proteolytic part of the 20S core proteasome, where
the degradation of polypeptides and proteins takes place. β-type
subunits possess protease activities and have been conserved
through evolution. 20S proteasome exhibits three different proteo-
lytic activities; caspase-like activity that cleaves after acidic amino
acids with β1 subunit being the responsible one, trypsin-like
activity that cleaves after basic amino acids with β2 subunit
being the responsible one and chymotrypsin-like activity that
cleaves after large hydrophobic and neutral amino acids with β5
subunit being the responsible one [72]. The catalytic center of each
proteolytic subunit contains an N-terminal threonine residue
(Thr1) [103]. Additionally, the three-dimensional structure of the
proteolytic center of each of these subunits is stabilized by a set of
serines, Ser129/166/169. In C. elegans all seven β-type subunits
(pbs-1 to pbs-7) have been mapped [24], bearing a statistical
signiﬁcant homology with the ones found in H. sapiens and
S. cerevisiae.
The pbs-1 gene encodes for a protease subunit with high
similarity to the human proteasome type-6 beta subunit that affects
fertility, embryonic viability, locomotion, and larval viability [76,154].
The pbs-2 gene encodes for a protease subunit loss of which has been
found to affect apoptosis, fertility and embryonic development [48].
Table 1
The orthologues of the human 20S proteasome subunits in C. elegans.
α-type subunits β-type subunits
C. elegans H. sapiens C. elegans H. sapiens
Gene name
pas-1 PSMA6 pbs-1 PSMB6
pas-2 PSMA2 pbs-2 PSMB7
pas-3 PSMA4 pbs-3 PSMB3
pas-4 PSMA7 pbs-4 PSMB2
pas-5 PSMA5 pbs-5 PSMB5
pas-6 PSMA1 pbs-6 PSMB1
pas-7 PSMA3 pbs-7 PSMB4
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The pbs-2 gene shows high similarity with the human type-7 beta
subunit. The pbs-3 gene encodes for a type-3 beta subunit of the 20S
core. By homology, PBS-3 is predicted to function in the ATP/
ubiquitin-dependent non-lysosomal protein degradation and loss of
PBS-3 activity indicates that, in C. elegans, PBS-3 is required for
embryonic and germline development, movement, normal body
coloration, and normal body morphology [76,154]. The pbs-4 gene
encodes for a type-2 beta subunit of the human 20S proteasome.
PBS-4 is predicted to function in the ATP/ubiquitin-dependent non-
lysosomal protein degradation, as PBS-3, and loss of PBS-4 activity
reveals that PBS-4 is required for embryonic, germline, and larval
development [38,167,154]. The pbs-5 gene encodes for a type-5 beta
subunit, loss of which leads to reduced apoptosis, embryonic lethality
and defects in locomotion [48,166,154]. The pbs-6 gene encodes for
the similar to vertebrates β1 subunit of the 20S proteasome. Its loss
results in embryonic lethality and defects in egg laying, larval
development, morphology and movement [48,154,166]. The pbs-7
gene encodes for the similar to β4 mammalian subunit of the 20S
proteasome. By homology, PBS-7 is predicted to function in the
ATP/ubiquitin-dependent non-lysosomal protein degradation. Loss
of PBS-7 activity indicates that PBS-7 is required for normal move-
ment and for embryonic, germline, and larval development
[38,126,154].
26S proteasome
The 26S proteasome is an over 2 MDa molecular machine that
is consisted by more than 30 different subunits. This large multi-
subunit protease is ubiquitous in eukaryotic cells and plays a key
role in cellular proteostasis. 26S proteasome consists of one 20S
barrel-shaped proteolytic core complex and two 19S regulatory
complexes that cap both ends of the 20S core complex, attached to
the α-rings.
19S regulatory complex is responsible for the recognition,
deubiquitination and translocation of the ubiquitinated substrates
that are rapidly broken down into short peptides [44]. 19S
regulatory particle is divided into a ring-like base, which consists
of six different ATPases and a few non-ATPases, and a lid-like
structure, which only consists of non-ATPases subunits. These two
structures are considered to be linked through Rpn10 and Rpn13
subunits. Table 2 summarizes the orthologues of the 19S human
proteasome subunits in C. elegans.
Base complex. The ring-shaped base [116] consists of six different
ATPases of the AAAþ family (ATPase Associated diverse cellular
activities), namely Rpt1-6, and two non-ATPases, namely Rpn1
and Rpn2. The base complex binds in each side of the 20S core
proteasome over the α-rings. Its speciﬁc role is (a) the recognition
of the ubiquitinated proteins, (b) the ATP-dependent unfolding of
the substrates, (c) the opening of the 20S core gate via allosteric
reactions and ﬁnally, (d) the translocation of the ubiquitinated
protein substrate inside the 20S catalytic particle.
In C. elegans, Rpt-1 is the orthologue of the human 26S protease
regulatory subunit 2 (S7). The rpt-1 gene expression affects
fertility and embryonic viability ([24,76,77,126,154]), along with
the expression levels of rpn-2 [164], daf-2 (receptor of the insulin-
like pathway, abnormal DAuer Formation-2) and glp-1 (abnormal
Germ Line Proliferation 1) [43]. Rpt-2 is the orthologue of the
human 26S protease regulatory subunit 1 (S4) and is shown to
affect embryonic lethality [126,167] and lifespan expectancy via
regulation of glp-1 gene expression [43]. The rpt-3 gene is required
for embryonic, larval and germline development [51,167]. By
homology with the human isoform 1 of the 26S protease regula-
tory subunit 4 (S6B), it is predicted to function in unfolding protein
substrates and translocating them into the core proteasome. It has
been also found to interact with daf-2 and glp-1 to regulate
lifespan expectancy [43] and with fog-2 (Feminization Of Germ-
line) to regulate oocyte maturation [46]. The rpt-4 gene encodes
for another ATPase subunit that affects body morphology,
embryonic viability, growth, movement and fertility
[124,157,24,76,154], sharing homology with the human 26S
protease regulatory subunit 6 (S10B). RPT-4 interacts with many
viability and growth signiﬁcant proteins such as DAF-2, GLP-1
[43], ZYG-1 (ZYGote defective 1) [124], HSP70 (Heat Shock
Protein 70), GST-4 (Glutathione S-Transferase 4), PAS-6 and
PBS-6 [97]. The rpt-5 gene is required for embryonic, larval and
germline development development [38,126,167] and by homol-
ogy with human 26S protease regulatory subunit 3 (S6A), is
predicted to unfold protein substrates and to translocate them
into the core particle. It has been found to regulate genes such as
daf-2 and glp-1 [43] and to be regulated by PAS-5 and PBS-4
subunits and the SKN-1 transcription factor [97]. RPT-6 is the last
ATPase of the 19S particle. The rpt-6 gene, the orthologue of
human 26S protease regulatory subunit 5 (S8), is required for
embryonic and larval development [51,167]. RPT-6 has been
found to suppress the expression of daf-2 and glp-1 genes, thus
leading to shortened lifespan [43].
Concerning the non-ATPase subunits, RPN-1 is a component of
the 19S base subcomplex. The activity of RPN-1 is essential for
embryonic, larval and germline development [167,152]. rpn-1 is
the orthologue of 26S proteasome non-ATPase regulatory subunit
2 and is predicted to function in unfolding and recognition of
protein substrates and/or recycling of ubiquitin moieties during
protein degradation. Its expression seems to suppress daf-2 and
glp-1 genes expression [43] and to regulate the expression levels
of gpdh-1 (Glycerol-3-Phosphate DeHydrogenase 1) [91,92] and
rpn-2 genes [164]. RPN-2, the orthologue of the isoform 2 of 26S
proteasome non-ATPase regulatory subunit 1, is required for
embryonic, larval and germline development [51,167,48]. It is
expressed sporadically at all stages of development in the pharynx,
intestine, body wall muscle, somatic gonad, neurons, and hypo-
dermis [107,108] and regulates the expression levels of many
genes such as several 26S proteasomal subunits, hsp-70, gst-10
(Glutathione S-Transferase 10), gcs-1 (gamma GlutamylCysteine
Synthetase) [97], gst-4 [97,18], daf-2, glp-1 [43], gpdh-1 [91].
It is regulated by SKN-1 factor [97] and RPN-1 and RPT-1 19S
subunits [164].
Lid complex. 19S lid subcomplex consists only of non-ATPases
subunits that play a critical role in the process of degradation of
ubiquitinated substrates as well as in additional functions that
are not involved in the proteasome-mediated proteolysis
process. These non-ATPases share a PCI domain which serves
as a scaffold for the protein–protein interaction and seem to
Table 2
The orthologues of the human 19S proteasome subunits in C. elegans. The ATPases
are shown in green background.
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regulate the assembly and the maintenance of the structural
integrity of the proteasomal machine [65,189]. The main role
of the 19S lid is to recognize ubiquitinated protein substrates
and to detach the ubiquitin molecules from them. Given that
these subunits have no enzymatic activity (with the exception
of Rpn11), it is unlikely to participate in other functions of
the lid.
In C. elegans, the rpn-3 gene, the orthologue of the human 26S
proteasome regulatory non-ATPase subunit 3, plays an important
role in embryonic viability [154,51], development [141,142] and
growth [43]. RPN-3 has been found to suppress the expression of
daf-2 and glp-1 genes and to promote a shortened lifespan [43]. The
rpn-5 gene has an important role in embryonic lethality [166]
sharing homology with the human 26S proteasome non-ATPase
regulatory subunit 12. The rpn-6.1 gene, the orthologue of the
human 26S proteasome non-ATPase subunit 11 variant, affects
embryonic, larval and adult viability, fertility, and osmotic regula-
tion [51,24,76,154]. It interacts with daf-2 and glp-1 by suppressing
them [43], with gpdh-1 by modulating its expression levels [91]
while it is also regulated by glp-1 [175]. The rpn-7 gene affects
fertility and embryonic viability [104,126,24] and, by homology,
resembles to the human 26S proteasome non-ATPase regulatory
subunit 6. RPN-7 was found to suppress the expression of daf-2 and
glp-1, thus leading to a shortened lifespan of the worm [43] and to
regulate the expression of gst-4 [19] and pqn-47 (Prion-like-(Q/N-
rich)-domain-bearing protein) [115]. RPN-8 is the product of the
orthologue gene of the human 26S proteasome non-ATPase reg-
ulatory subunit 7 and is shown to suppress the expression of daf-2
and glp-1 genes [43] and to modulate the expression levels of gst-4
[19]. The rpn-9 gene, sharing homology with the human 26S
proteasome non-ATPase subunit 13, affects body morphology,
embryonic and larval viability, locomotion, fertility, and growth
[24,76,126,154]. RPN-9 is found to alter the expression levels of gsc-
1 and gst-4 [177], to suppress the expression of daf-2 and glp-1 [43]
and to change the localization of SKN-1 factor [177]. RPN-10 is not
completely deﬁned whether it is a component of the base or the lid.
The rpn-10 gene is the orthologue of the human isoform Rpn10A of
the 26S proteasome non-ATPase regulatory subunit 4. It seems that
RPN-10 acts as a linker between these two structures attached to
RPN-12 of the lid and RPN-1 of the base. RPN-10 subunit has two
ubiquitin interacting motifs, which recognize the polyubiquitin
chains of the protein substrates through diverse conformations
of the protein helices. RPN-10 has a suppressing effect on several
genes, such as fem-3 (FEMinization of XX and XO animals) [152],
daf-2, glp-1 [43], lin-15A (abnormal cell LINeage, vulval develop-
ment), lin-15B, lin-8 [23], and alters the expression levels of tra-2
(TRAnsformer: XX animals transformed into males, transmem-
brane receptor of the sex determination pathway) [152] and unc-
45 (UNCoordinated, muscle-speciﬁc protein) [67]. The rpn-11
gene, orthologue of the human 26S proteasome non-ATPase
regulatory subunit 14, affects embryonic and adult viability,
osmoregulation and movement [24,76,154]. RPN-11 is a metallo-
proteinase of the JAMM domain family containing a conserved
metal binding site [1] thus acting as a crucial deubiquitinating
enzyme (DUB) of the 26S proteasome [174,187]. RPN-11 sup-
presses the expression of daf-2 and glp-1 genes resulting to a
shortened lifespan [43]. Li and colleagues [98] have shown that
rpn-11 expression levels are regulated by several genes such as
skn-1, eef-2 (Eukaryotic translation Elongation Factor), rpn-2 and
pas-5. The rpn-12 gene shares homology with the human 26S
proteasome non-ATPase regulatory subunit 8. RPN-12 suppresses
the expression of glp-1 [43], lin-15A, lin-15B, lin-36, lin-8 [23] and
gpdh-1 [91] while rpn-12 gene expression is regulated by several
genes, such as skn-1, eef-1A.1, eef-2, eif-1 (Eukaryotic Initiation




The 20S core undergoes a very complex and highly regulated
intracellular assembly in eukaryotic cells. The 20S proteasome
assembly involves a set of proteasome-speciﬁc chaperons, called
PACs (Proteasome Assembling Chaperones). Up to now, 4 different
PACs, namely PAC1–PAC4, have been revealed [97,188], but their
homologues in C. elegans have not been identiﬁed yet. PAC1 and
PAC2 form heterodimers, as PAC3 and PAC4 do. PAC1–2 is built in
order to assemble the α-ring, resulting in the activation of PAC3–4
dimer which starts the step-by-step incorporation of the β sub-
units to form the β-ring. More speciﬁcally, α5 and α7 subunits are
the ﬁrst ones that take place on the PAC1–2 complex and they are
followed by α6, α1, α2, α3 and α4 subunits. After the formation of
the α-ring, PAC3–4 attaches to the α2 subunit of the α-ring and
initiates the assembly of the β-ring starting by the attachment of
β2 and β3 subunits. Attachment of β3 is followed by disassocia-
tion of PAC3–4 complex and the binding of Ump1 (in yeast,
POMP in humans) molecule (proteasome maturation factor)
[97,17]. β4–β7 and β1 follow the stepwise incorporation of the
rest β subunits in the β-ring [58]. After this procedure, the
intermediates formed contain one complete α- and one com-
plete β-ring as well as a PAC1–2 complex and an Ump1 factor.
Hsc73 is a heat shock protein which is involved in the further
dimerization of the two intermediates mentioned above and
are called 16S intermediates or half-proteasomes. After this
step, Hsc73 detaches and proteolytic active subunits, β1, β2 and
β5, are activated through autocatalysis of their own pro-
peptides. The ﬁrst substrate to be degraded is the Ump1 factor
that is then followed by the degradation of the two PAC1-2
complexes.
19S assembly
Base complex. As it was mentioned above, 19S regulatory particle
consists of two structures, the base and the lid. The assembly of
the 19S regulatory particle of the proteasome initiates with
the incorporation of the base subunits. Firstly, 3 different stable
intermediates are formed, namely RPN1–RPT2–RPT1–Hsm3,
Nas2–RPT3–RPT6–RPN14 and Nas6–RPT5–RPT4. Hsm3, Nas2,
Nas6 and RPN14 are 19S-speciﬁc assembly factors and none of
them is present on the mature 26S proteasome [144,113,140].
Nas2–RPT3–RPT6–RPN14 may act as the seed of the assembly of
the 19S base particle. Subsequently, the three initiative inter-
mediates assemble into the base complex and RPN2 and RPN13
bind onto it, to join the full base complex, which will attach to the
lid via RPN10. Then, the chaperones Hsm3, RPN14, Nas6 are
released through the addition of RPN10.
Lid complex. The assembly of the 19S lid complex is not yet
fully understood. Recent studies suggest that the lid assembly
is a multistep process [66,149,40]. To date, RPN5, RPN6, RPN8
and RPN9 are the ﬁrst subunits to be incorporated to a stable
intermediate that are then followed by the association of RPN3,
RPN7 and RPN15 subunits. These two intermediates are associated
via the interaction between RPN3 and RPN5 subunits. The lid
is formed after the ﬁnal incorporation of RPN11 and RPN12
subunits [149,168]. Hsp90 (Heat Shock Protein 90) [64] and Yin6
(orthologue of the mammalian Int6) [147] are two of the factors
that are known to be involved in the lid formation in yeast.
As far as the association of 19S regulatory particle and 20S core
particle is concerned, there has been found a so-called modulator
complex that facilitates it. This modulator complex consists of
three factors: RPT-4, RPT-5 and p27 (Cyclin-dependent kinase
inhibitor 1B) [35].
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Protein degradation
The UPS system consists of the ubiquitin system that is
responsible for the recognition of the candidate for degradation
protein and for its “tagging” with ubiquitin, and the proteasome
system that performs the degradation of the protein. There are
several proteins and enzymes that are recruited in UPS in order to
perform the recognition, the tagging and the degradation, namely
ubiquitin, E1–E3 ligases and deubiquitinases. Ubiquitin is cova-
lently attached to the protein to be degraded in a multistep
process coordinated by the sequential action of E1–E3 ligases
[59]. The ubiquitin-activating enzyme (E1) is the ﬁrst one to act by
adenylating the C-terminal glycine of ubiquitin and forming
a thioester bond between the activated glycine residue and a
cysteine residue on the E1 catalytic site, through an ATP-
dependent mechanism. The product of this reaction is a reactive
E1–ubiquitin thioester intermediate. The activated ubiquitin is
then passed to a conserved E2 active-site cysteine of a ubiquitin-
conjugating enzyme (E2) by transthiolation. Meanwhile, a speciﬁc
ubiquitin-protein ligase (E3) has already recruited the target
protein and mediates the transfer of the activated ubiquitin from
the E2 enzyme to the substrate. In most cases, an ε-NH2 group of a
lysine residue on the tagged protein attacks the thioester bond
between the ubiquitin and E2, and an isopeptide bond is formed,
linking the activated C-terminal glycine of ubiquitin to the amino
group in the attacking lysine of the target substrate [129]. If
however, the substrate does not have any accessible lysine
residues, ubiquitin can be conjugated to the α-amino group of
the N-terminus of the target protein [135]. This ubiquitination
cycle is successively repeated, thus producing polyubiquitin chains
on the target protein (according to the sequential addition model).
It has been shown that at least 4 ubiquitin residues are needed for
efﬁcient recognition and processing by the 26S proteasome
[127,169].
Ubiquitin
Ubiquitin (Ub) is a small protein composed of 76 amino acids that
is highly conserved in eukaryotes [170]. In C. elegans there are two
loci, namely ubq-1 and ubq-2. ubq-1 is a polyubiquitin locus [47]
which produces a polyubiquitin protein and is post-translationally
cleaved into 11 Ub molecules by ubiquitin C-terminal hydrolases
[69,56,57]. ubq-2 is a conserved locus in eukaryotes with an intact
canonical Ub sequence fused to the ribosomal large subunit protein
(L40) [70]. When the protein product is cleaved, Ub molecule is
functional to be used for protein targeting [120]. Ubiquitin folds up
into a globular structure and is found ubiquitously throughout the
cell, but it can exist either as a free monomer or as part of a complex
(polyubiquitin chains) attached to other proteins.
E1 enzymes
As far as the polyubiquitin chains are concerned, Ub molecule is
conjugated to proteins through the bond between the glycine at its
C-terminus and a lysine of the target protein. Conjugation process
depends on the hydrolysis of ATP [128,130] and on the activation of
the Ubmolecule by an ubiquitin-activating enzyme (E1). In C. elegans,
there is only one such enzyme, UBA-1 [89], disruption of which
results in complete inactivation of the UPS proteolysis
[126,51,104,76,149].
E2 enzymes
As a kind of an intermediate step, UBA-1 transfers the activated
Ub molecule to an ubiquitin-conjugating enzyme (E2 ligases or
UBCs). In C. elegans there are 22 proteins that act as E2 enzymes
which are numbered as UBC-1–3, UBC-6–9 and UBC-12–26, but
their numbering is not corresponding to the UBCs of S. cerevisiae
and humans [71,104,31,146,76]. UBCs are attached to the
C-terminal glycine 76 of the Ub molecule via a thioester bond
and each of these can activate a special set of E3 enzymes in order
Table 3
Ubiquitin-conjugating enzymes (E2), UBCs, their orthologues in humans and the observed phenotype in C. elegans upon RNAi treatment or in mutants.
Gene orthologous grouping Phenotype following RNAi treatment or in mutant strains References
C. elegans H. sapiens





Embryonic and larval lethality with defects in sarcomere assembly
[192,71]; Stevens and Candido, 1998;
[61,15]
ubc-3 CDC34;FLJ20419 WT [71,76]
ubc-6 NCUBE1 WT [71,85]
ubc-7 UBE2G1 WT [104,62,67]
ubc-8 UBE2H WT [80]
ubc-9 UBE2I
Deﬁciencies in embryogenesis, larval development,
vulval development, posterior morphogenesis and DNA damage
response
[9,71]; Leight and Kornfeld, 2002
ubc-12 UBE2M
Deﬁciencies in embryogenesis and terminal hypodermal
differentiation, embryonic arrest, vulval eversion at L4 stage,
defective alae
[71]
ubc-13 UBE2N; BAA93711 Embryonic lethality and reduced brood size [71,141,142,87]
ubc-14 UBE2G2
Embryonic lethality at a stage after gastrulation
but prior to muscle twitching, and abnormal larval tail morphology
[71]
ubc-15 NCUBE1 WT [71,76]
ubc-16 BAA91954 WT [71]
ubc-17 BAB14320;BAB14724 WT [71]
ubc-18 UBE2L1;UBE2L3/UBCH7;UBE2L6 Reduced growth rate and brood size [71,31]
ubc-19 - Unhealthy larvae [104]
ubc-20 HIP2 Late larval arrest and reduced brood size [71,95]
ubc-21 HIP2 WT [71]
ubc-22 UBE2L1;UBE2L3/UBCH7;UBE2L6 WT [80,85]
ubc-23 HIP2 WT [80]
ubc-24 - Reduced fat content-lipid metabolism [80,3]
ubc-25 UBE2Q1; UBE2Q2 Defective postembryonic neuromuscular function [146]
ubc-26 NCUBE1 – [85]
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to produce a lot of different E2–E3 combinations for each target
protein. Table 3 summarizes the UBCs found in C. elegans.
E3 enzymes
These proteins are ubiquitin-protein ligases which act as a
bridge between an Ub-loaded E2 enzyme and the protein sub-
strate. There are mainly four classes of ubiquitin-protein ligases:
HECT-domain proteins, U-box proteins, monomeric RING ﬁnger
proteins and multisubunit complexes that contain a RING ﬁnger
protein [123].
HECT-domain proteins. Up to now, 9 HECT-domain E3 ligases have
been identiﬁed in C. elegans that however are not widely studied.
In HECT-domain proteins, the Ub molecule is transferred to a
conserved cysteine residue of the E3 ligase through a thiolester
linkage, and then the E3 transfers the Ub to the protein substrate.
Table 4 summarizes the known HECT-domain E3 ligases in
C. elegans.
U-box domain proteins. U-box domain proteins are encoded by
four genes in C. elegans and act as E3 or E4 (ubiquitin-chain
elongation factor) enzymes. The chn-1 gene encodes for a protein
orthologous to the human CHIP. RNAi treatment in worms showed
that CHN-1 is essential for the larval development and viability
[81]. Another gene that encodes for a U-box domain protein is cyn-
4 or cyp-4 or mog-6, a divergent member of the cyclophilin family
orthologous to human hCyP-60. CYN-4 activity is required for the
sperm to oocyte switch, robust germline proliferation and for the
mitosis or meiosis decision. Loss of cyn-4 via RNAi results to
morphological defects at early larval stages [121,5,125,79]. The ufd-
2 gene encodes for an E4 enzyme orthologous to S. cerevisiae
Ufd2p and to human UBE4B, which both catalyze multiubiquitin
chain assembly. RNAi treatment of ufd-2 results in increased
protein expression and feminization of the germline [152]. The
last of the U-box domain genes, prp-19, encodes for a yeast PRP
(splicing factor) related protein, loss of which leads to embryonic
lethality [76,141,142,166,55] and sterility [48,55].
Monomeric RING ﬁnger proteins. With regard to the monomeric
RING ﬁnger proteins, there have been found 15 in the C. elegans
genome [85], but it is not clear if all of them act in vivo as
E3 ligases. The RING ﬁnger motif consists of eight histidine or
cysteine residues that bind two Zn2þ ions in a cross-like structure
[30]. The monomeric RING ﬁnger proteins bind both to the E2
enzyme and the substrate protein in order to catalyze the
transaction of the ubiquitin molecule to the substrate. There are
two classes of monomeric RING ﬁnger proteins: the ones that
share the motif H2 and those that share the motif HC [30]. RNAi
treatment of the majority of these proteins present a phenotype
without abnormalities (WT), while the rest are involved in
embryonic and larval development, so as in sterility
[85,76,104,71,166,51,111,48].
Multisubunit RING ﬁnger complexes. The ﬁnal category of E3 ligases
consists of the multisubunit complexes that contain a RING ﬁnger
protein, and are subcategorized into 4 classes based on the
participating cullin protein: CUL-1, CUL-2, CUL-3 and CUL-4. Six
different cullin genes have been found in the C. elegans genome
(cul-1 to cul-6; [86]).
The CUL-1-based complexes are known as SCF complexes
because they consist of an adaptor which acts as a ligand between
an F-box domain protein, Skp-1, a cullin, CUL-1, and an F-box
domain protein which is the substrate recognition subunit and is
placed between Skp-1 and the substrate protein. Among the other
components of the SCF complex, there is the RBX-1 protein which
bridges the CUL-1 and the Ub-bound E2 enzyme. There are more
than 326 F-box domain proteins in C. elegans, in comparison
with humans and S. cerevisiae and they form numerous combina-
tions with SKRs (Skp-1-Related proteins, 21 different proteins in
C. elegans) which are different in every complex, so as more
proteins can get recognized for ubiquitination. The most known
and well-studied SCF complexes are SCFLIN-23 [83,114,124,43],
SCFSEL-10 [62,124,25,184] and SCFFSN-1 ([99,63,109]).
The CUL-2 based complexes are very similar in structure to
SCFs. They consist of a CUL-2, an Skp-1 related elongin C (ELC-
1), an elongin B (ELB-1) and an RBX-1 protein. ELC-1 binds to
the substrate protein via a BC-box motif [78] and to ELB-1
which contains an ubiquitin-like domain [84]. During devel-
opment, CUL-2 regulates diverse biological processes via the
ubiquitin-mediated proteolysis, such as the initiation of meio-
tic anaphase II, cytokinesis and mitotic chromosome segrega-
tion, embryonic cell fate speciﬁcation and sex determination.
CUL-2 is expressed in diverse cell types during embryonic and
larval development and is also expressed in the adult germ line
[32,28,158,161].
The CUL-3-based complex does not share the exact same structure
with CUL-1 and CUL-2-base complexes. A single protein, namely BTB/
POZ-domain protein, acts as both the adaptor of the CUL-3 to the
substrate-protein and the substrate recognition subunit. There are over
100 BTB-domain genes in C. elegans, resulting in many combinations
for CUL-3-based complexes [172,41,162,185]. The cul-3 gene encodes
for one of the six C. elegans cullins and in the early embryo, maternal
CUL-3 is essential for degradation of MEI-1, a meiosis-speciﬁc subunit
of the microtubule-severing katanin complex, via MEL-26, a substrate-
speciﬁc adaptor protein that also binds MEI-1. CUL-3 activity is
regulated by cycles of neddylation and deneddylation
[132,185,90,180,68].
The CUL-4-based complex structure is not yet fully studied. The
cul-4 gene encodes for a cullin protein whose activity is essential
for negative regulation of DNA-replication licensing and thus, for
maintenance of genome stability. CUL-4 functions as part of a CUL-
4/DDB-1 ubiquitin ligase complex that degrades the replication
licensing factor CDT-1 during S phase. It also promotes nuclear
export of the replication licensing factor CDC-6 by negatively
regulating the levels of the CKI-1 CDK inhibitor, in order to
regulate DNA replication [19,193,83]. DDB-1 protein acts as an
adaptor and substrate recognition subunit of the CUL-4-based
complex [82].
CUL-5 and CUL-6 are not part of these 4 classes of E3 ligases.
CUL-5 is not involved in the degradation process [186,76] and little
is known about CUL-6 [114].
Apart from the multisubunit RING ﬁnger cullin-based com-
plexes, there are multisubunit RING ﬁnger APC/C complexes.
APC/C complexes consist of nine core and two assistant compo-
nents in C. elegans. The two assistant components are FZY-1 and
FZR-1. APC/C complexes have been shown to have an important
role in the chromosome separation during meiosis I [42,148], in
the anterior–posterior polarity in the one-cell embryo [134], in the
regulation of cyclins during G1 phase [31] and in the regulation of
Table 4
HECT-domain ubiquitin ligases in C. elegans.
Gene name Phenotype upon RNAi treatment References
hecd-1 WT [23]





wwp-1 Embryonic lethality [4,166,155,34]
eel-1 Low range embryonic lethality [104,191]
Y92H12A.2 WT [38,104,76,166]
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the amount of GLR-1 glutamate receptors in the nerve cells of the
ventral cord [73].
Deubiquitinases
Ubiquitination is a reversible post-translational modiﬁcation
with key roles in various signal transduction cascades and a
well-documented role in determining protein stability. Deubiqui-
tinating enzymes (DUBs) are a large group of proteases [179] that
cleave ubiquitin from protein substrates and other molecules
[136,137]. DUBs are also known as deubiquitinases, deubiquitinat-
ing peptidases, ubiquitin isopeptidases, deubiquitinating isopepti-
dases, ubiquitin proteases and ubiquitin hydrolases. DUBs have
been implicated in several important pathways including cell
growth and differentiation, development, neuronal disease and
transcriptional regulation. DUBs also play several roles in the
ubiquitin pathway. One of the best functional characteristic of
DUBs is the removal of monoubiqutin and polyubiquitin chains
from proteins since they can cleave the peptide or isopeptide bond
between ubiquitin and the protein substrate where ubiquitin is
attached. Therefore, DUBs possess an antagonistic role in the axis
of ubiquitination through the reversal of the fate of the proteins
[136,137]. Free polyubiquitin chains are also cleaved by DUBs to
produce monoubiquitin. The chains may be produced by the
E1–E2–E3 machinery in the cell, free from any substrate protein.
More speciﬁcally, DUBs function has major effects on the regula-
tion of protein half-life and quality. DUBs activities include the
cleavage of ubiquitin precursors, the editing and rescuing of
ubiquitin conjugates, the coupling of protein deubiquitination
and proteasome-mediated degradation, the disassembly of ubi-
quitin oligomers and the deubiquitination and membrane protein
trafﬁcking [2].
In humans there are nearly 100 genes and in C. elegans 45
genes that encode for deubiquitinating enzymes, which can be
classiﬁed into two main classes: (a) cysteine proteases and,
(b) metalloproteases. Both of these classes are subcategorized;
cysteine proteases comprise ubiquitin-speciﬁc proteases (USPs),
Machado–Josephin domain proteases (MJDs), ubiquitin C-terminal
hydrolases (UCHs), ovarian tumour proteases (OTU) and metallo-
proteases consist of JAMM domain proteases. USPs undergo
a variety of sizes (50–300 kDa) usually produced by different
N-terminal extensions which may function in substrate recogni-
tion, subcellular localization and protein–protein interactions.
USPs can process ubiquitin precursors, remove ubiquitin from
protein conjugates and disassemble ubiquitin chains. In contrast,
UCHs are relatively small enzymes (20–30 kDa). They catalyze the
removal of peptides and small molecules from the C-terminus
of ubiquitin. Most UCHs cannot generate monomeric ubiquitin
from protein conjugates or disassemble poly-ubiquitin chains. The
JAMM isopeptidases (which bind zinc), otubains and ataxin-3/
josephin have been identiﬁed as ubiquitin-speciﬁc proteases [133].
There are also enzymes that speciﬁcally hydrolyze C-terminal
isopeptide bonds for ubiquitin-like proteins: SUMO-speciﬁc pro-
teases (SENPs), NEDD8-speciﬁc proteases (COP9 signalosome) and
ISG15-speciﬁc proteases (UBP43) [182]. Table 5 summarizes the
deubiquitinases identiﬁed in C. elegans.
UPS regulation
The subunits and pathways that have been shown to either up-
or down-regulate the UPS function upon their modulation are
discussed below. Fig. 1 summarizes these factors.
Upregulation of proteasomal function in C. elegans
There are several chemical and genetic factors that can promote
the upregulation of the proteasome function. Studies have focused
on these mechanisms in order to reveal proteasome activators that
can be used in putative anti-ageing or homeostasis maintaining
strategies. Several genes are responsible for the regulation of the
proteasome and as far as C. elegans is concerned, a number of
studies have focused on the mechanisms that are involved in the
degradation of muscle proteins, nervous system proteins, patho-
logically aggregated and oxidized proteins, so as to pathways
that are involved in the worm development and sex determina-
tion. The various UPS-related factors that have been shown to
result in upregulation of the proteasome function in C. elegans are
summarized below.
19S proteasome subunits
AIP-1 is an arsenite-inducible protein and component of the
proteasome 19S regulatory cap, which is encoded by an early-
induced gene and has been found to protect against Aβ induced
paralysis caused by accumulation of the toxic peptide in a C.
elegans strain that serves as a model for Alzheimer0s disease. AIP-1
is the homologue of the mammalian AIRAP and it was reported
that its expression increases the accessibility of the protein
Table 5
DUBs genes and their catalytic cores in C. elegans.
Deubiquitinating enzymes (DUBs)
Gene category OTU JAMM USP UCH MJD
Catalytic core Cys–His–Asp His–Asp–Zn2þ Cys–His boxes Cys–His boxes Cys–Gln–His–Asp
Gene name otub-1 csn-5 math33 C04E6.5 ubh-1 atx-3
otub-2 eif-3.H H34C03.2 usp-14 ubh-2 Y67D2.2
otub-3 prp-8 K02C4.3 C34F6.9 ubh-3
otub-4 eif-3.F K08B4.5 F07A11.4 ubh-4
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substrate to the proteasome, assists to the adaptation of the
worms under proteotoxic stress [190] and facilitates the degrada-
tion of damaged proteins in stress response conditions e.g.
following arsenic treatment or fumarylacetoacetate or maleylace-
toacetate treatment [33,54]. In contrast, animals maintained in
aip-1 RNAi exhibit a shorter median lifespan [190]. In accordance
with these results, AIRAP, the mammalian homologue of AIP-1, has
been shown to exert a protective role in mammalian cells follow-
ing arsenite treatment [156]. More recently, it was revealed that
overexpression of AIRAP modulates the 20S core proteasome to
counteract proteotoxicity induced by an environmental toxin like
arsenite [160]. More speciﬁcally, association of AIRAP with the 19S
cap leads to enhanced cleavage of peptide substrates thus enabling
cells to cope with the arsenite-induced proteotoxicity [160].
Modulation of the proteasome activity has been recently
achieved through overexpression of a 19S subunit in C. elegans.
More speciﬁcally, Vilchez and colleagues [175] have revealed that
glp-1 mutants, which lack their germ line, exhibit markedly
increased proteasome activity in addition to decreased levels of
polyubiquitinated proteins. A 19S proteasome subunit, namely
rpn-6.1, has been identiﬁed to be necessary for this phenotype.
Overexpression of this subunit leads to increased proteasome
activities, increased survival to various stresses, and ameliorated
response to proteotoxicity and lifespan extension under conditions
of mild heat stress at 25 1C but not at 20 1C. Accordingly, protea-
some activity in human embryonic stem cells has been shown to
be correlated with increased levels of the 19S subunit, PSMD11, the
orthologue of RPN-6 in humans [176].
In total, the similarities between the results in C. elegans and in
mouse and human cells dictate that worms constitute a valuable
model to study alterations of different constituents of the UPS.
E2 and E3 ligases
Overexpression of wwp-1, a HECT E3 ligase, has been shown to
promote a 20% lifespan extension under conditions of ad libitum
feeding while it is absolutely required for the extension of lifespan
following dietary restriction (DR). Moreover, the speciﬁc E2 ligase
that is responsible for the regulation of DR induced longevity,
namely UBC-18 has been also identiﬁed [13]. The authors sug-
gested that these two enzymes coordinate the ubiquitination of
substrates that regulate DR-induced longevity. In accordance, it
was recently revealed that overexpression of the human WWP1
delays cellular senescence in human ﬁbroblasts, while its knock-
down promotes irreversible premature senescence. The authors
revealed a reverse correlation between the protein levels of
p27(Kip1) and WWP1, thus suggesting that WWP1 promotes the
ubiquitin-mediated degradation of the endogenous p27 (Kip1)
Fig. 1. Genes, pathways and compounds that have been identiﬁed to alter the UPS function in C. elegans. Factors that have been revealed to alter the UPS function in C.
elegans in terms of proteasome activities and/or assembly and/or expression. These factors include different molecular pathways and natural or chemical compounds along
with alterations in the various components of the UPS system (e.g. proteasome subunits, E2 and E3 ligases, DUBs). Positive regulators are shown in green whereas negative
regulators are shown in red. The regulators that have been shown to be redox sensitive are underlined.
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[12]. Nevertheless, WWP1 E3 ligase was not shown to have any
impact on the long lifespan of animals with reduced IIS pathway.
In contrast, Ghazi and colleagues [43] have revealed components
of the Skp1-Cul1-F-Box E3 ligase that play a pivotal role in the
extended lifespan of IIS mutants by affecting DAF-16/FOXO activity.
Sex determination in C. elegans is characterized by numerous
procedures including regulated degradation of speciﬁc proteins. TRA-
1 plays a major role in sex determination of C. elegans. It has been
found that p97 (CDC-48 in C. elegans), an ubiquitin-selective AAA
chaperone, interacts with CUL-2/NPL-4 complex in order to upregu-
late the proteasome-mediated degradation of TRA-1 and thus to
result to sex determination [145]. CBCFEM-1 is also a complex that
targets TRA-1 proteasome-dependent degradation and has the same
effect on proteasome-mediated degradation as p97 [161]. Previous
studies have also revealed that SEL-10, an F-Box protein which
regulates LIN-12 Notch signaling and promotes female development,
increases the levels of proteasome-mediated degradation of FEM-1
and FEM-3, proteins which are responsible for the primary sex-
determining signal [74].
Deubiquitinases
It was ﬁrstly revealed in yeast that upon ubiquitin stress (when
ubiquitin levels are low), the stress is sensed thus leading to the
induction of the proteasome-associated DUB Ubp6. As a result of this
induction, more proteasomes are loaded with Ubp6, thereby altering
proteasome function and consequently maintaining the ubiquitin
pool [53]. Lately, the role of speciﬁc DUBs in the modulation of the
UPS and the downstream effects in stress/proteotoxicity resistance
and longevity has been also examined in C. elegans. UBH-4 is a
proteasome-associated DUB in C. elegans required for protein home-
ostasis maintenance. RNAi of ubh-4 positively regulates the protea-
some activity without however affecting its abundance. Moreover,
UBH-4 was shown to slightly affect lifespan and brood size while
ubh-4 levels were found to differ in wt and daf-2mutants [106]. Most
importantly, it was shown that loss of uchl5, the human orthologue
of ubh-4, also increases UPS activity and the degradation of proteo-
toxic proteins in mammalian cells [106], thus further verifying the
value of C. elegans as a model organism to evaluate the consequences
of UPS modulation.
Other UPS-related elements
Ubiquitin-mediated proteasome function involves many pro-
teins, enzymes and large complexes. SUMOs are small ubiquitin-
related modiﬁers, with SMO-1 being the orthologue in C. elegans.
Recent studies have shown that in transgenic animals that over-
express human SUMO-1 and SUMO-2 there is an upregulation of a
cluster of genes encoding components of the UPS, such as ubc-9,
ulp-5, smo-1 and rfp-1 [143]. Moreover, SKR-1 and SKR-2 are SKP-1
mammalian homologues that are parts of the SCF complex which
mediates ubiquitination. These two proteins have been found to
act normally as upregulators of the proteasomal degradation of
ZYG-1 protein which is responsible for cell division regulation
[124]. Another complex that plays a key role in substrate ubiqui-
tination is the CHN-1/CHIP, which acts as an E3/E4 complex with
chaperone-like function and is expressed in both the nervous
system and the musculature. CHN-1/CHIP has been shown to
target substrates for ubiquitination and proteasome-mediated
degradation [118]. Furthermore, DCN-1, a protein with an UBA-
like ubiquitin-binding domain required for cullin neddylation, has
been also found to upregulate the 26S proteasome activity [90].
Various redox conditions and molecular pathways
IIS and EGF signaling pathway are two main pathways that play
a key role in C. elegans growth and differentiation. DAF-2 is the
main receptor of the IIS pathway in C. elegans that has been shown
to upregulate the proteasome activities [163]. More speciﬁcally,
using mutants that do not express the functional DAF-2 receptor,
Stout and colleagues [163] have revealed that in daf-2 mutants
where daf-16 expression is increased, worms exhibit a lower
proteasomal activity. Moreover, they have shown that in these
mutants the whole mRNA transcription and translation levels
were reduced, thus leading to lower levels of misfolded proteins
and indicating that the normal function of DAF-2 receptor confers
enhancement of proteasomal activity. Consistent with these ﬁnd-
ings Bowerman and colleagues [10] showed that RLE-1, a
transposon-tagged allele, regulates the longevity of C. elegans by
promoting DAF-16 (transcription factor of the FOXO family that is
the downstream regulator of the IIS pathway in C. elegans)
polyubiquitination and proteasome-dependent degradation
through its direct binding onto DAF-16. Recent studies have also
revealed the positive role of EGF signaling via Ras–MAPK pathway
on the UPS activity which not only increases the proteasomal
function but also regulates the timing of the UPS activation
through SKR-5, a UPS component, and exerts regulation of the
organismal lifespan [100,101]. Finally, Vilchez and colleagues [175]
have suggested that in glp-1 mutants chymotrypsin-like protea-
some activity is increased through DAF-16 activation.
SKN-1 pathway is another signiﬁcant pathway in C. elegans that
has been shown to regulate the proteasome genes depending on
the redox conditions. SKN-1 transcription factor is the orthologue
of the mammalian Nrf2 that is responsible for the response to
oxidative stress as well as for detoxiﬁcation and defense against
free radicals and toxic small molecules. SKN-1 pathway has been
also linked to longevity [6,7,171] and to oxidative stress resistance
[75] in worms while it has been shown that it responds to
proteasome perturbations [19,75,119,122]. Upon proteasome
perturbation either following RNAi of proteasome subunits or
proteasome inhibition, SKN-1 is activated to produce a selective
oxidative-stress response that includes the upregulation of various
proteasome genes. Oxidative stress, caused by H2O2 pre-treatment
of worms, was also found to increase 20S proteasome activity and
simultaneously the expression levels of pas-7 subunit through
SKN-1 pathway, similarly to the effect of Nrf2 in mammalian cell
cultures [131]. In mature oocytes, there is a signiﬁcant elevation
of Reactive Oxygen Species (ROS) that cause cell cycle arrest
and results in an increase in the oxidatively damaged proteins.
Goudeau and colleagues [45] showed that when the yolk is
endocytosized, proteasome-mediated proteolysis is activated and
lowers the levels of oxidatively damaged proteins.
Treatment with ultraviolet radiation that causes DNA damage
in C. elegans cells has been shown to activate the innate immune
system of the worms and subsequently to positively modulate the
UPS to confer stress resistance [29].
Dietary restriction in worms through feeding with a low cell
density OP50 culture was also shown to increase the protein levels
of several α- and β-type subunits, components of the 20S core
proteasome, along with the increased expression of various sub-
units of the 19S regulatory complex [27].
Protein aggregation has a speciﬁc effect on proteasome activa-
tion. Vartiainen and colleagues [173] used transgenic worms that
overexpress A53T human synuclein, a protein responsible for the
formation of cellular inclusions in Parkinson Disease, Lewy Body
Dementia and Multiple System Atrophy. Increased RNA expression
levels of key ubiquitin-proteasome-relevant genes, such as pdr-1,
ubc-7, pas-5, pbs-4, rpt-2 and psmd9 were detected in these
transgenic animals.
Chemical or natural compounds
There are several compounds that have been shown to act as
proteasome activators in cell culture [20]. Nevertheless, up to now
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very few compounds have been examined as proteasome activa-
tors in C. elegans. Fu and colleagues [39] recently showed that
acetylcorynoline, the major alkaloid component derived from
Corydalis bungeana, a herb that is used in traditional Chinese
medicine, increases the expression levels of rpn-5, thus leading to
an enhanced activity of the proteasome in C. elegans. Under
hypertonic stress, caused by NaCl treatment, proteasome degrada-
tion is increased in order to protect from the accumulation of
damaged proteins induced by the stress [11].
Downregulation of proteasomal function in C. elegans
Several genes and mechanisms have been revealed to nega-
tively regulate the proteasome function in order to protect the cell
from an un-programmed or un-needed proteolysis. These compo-
nents are summarized below.
20S and 19S proteasome subunits
RNAi of various proteasome subunits has been shown to induce
proteasome dysfunction that in turn activates the SKN-1-mediated
stress response [75] but also the heat shock response [50]. RNAi of
proteasome subunits has been shown to confer a substantial
lifespan shortening in WT animals but also in various long-lived
mutants like the IIS mutants and the glp-1 mutants ([43,163]).
Additionally, in glp-1 mutants, knock-down of a 19S proteasome
subunit, namely rpn-6.1, has been shown to markedly decrease the
proteasome activity [175].
E3 ligases
RLE-1 is an E3 ligase that was identiﬁed to regulate C. elegans
ageing through polyubiquitination of DAF-16. Elimination of RLE-1
decreases the levels of DAF-16 polyubiquitination thus promoting
increased DAF-16 transcriptional activation that ultimately leads to
increased lifespan ([97]). WDR-23, a WD40 Repeat Protein, is
another protein that interacts with the CUL4/DDB1 ubiquitin ligase
and probably functions as a substrate recognition substrate. Loss of
wdr-23 has been shown to increase SKN-1 protein levels thus
revealing the regulatory role of WDR-23 on SKN-1 protein abun-
dance. As expected, loss of wdr-23 signiﬁcantly enhanced stress
tolerance and extended nematodes lifespan [19]. The C. elegans
von Hippel-Lindau tumor suppressor homologue of VHL-1 is
another cullin E3 ligase that negatively regulates the hypoxic
response by promoting polyubiquitination and degradation of
HIF-1 transcription factor. Consequently, loss of vhl-1 signiﬁcantly
increased resistance to proteotoxicity and lifespan [109].
Deubiquitinases
The Machado-Joseph disease deubiquitinase ataxin-3 (ATX-3)
was the ﬁrst DUB in C. elegans [139] to be shown to exert its
inﬂuence on longevity and proteostasis [88]. More speciﬁcally,
ATX-3 has been shown to interact with the chaperone-like AAA
ATPase CDC-48 (Cdc-48 in yeast, CDC-48 in C. elegans and p97 in
mammals) and thereby to hydrolyse polyubiquitinated proteins
[159,181]. Kuhlbrodt and colleagues [88] showed that the deubi-
quitinase activity of ATX-3 is trivial for normal lifespan in nema-
todes. Worms deﬁcient in both cdc-48.1 and atx-3 showed elevated
substrate stabilization (thus decreased degradation of the sub-
strate) and a 50% increased longevity that was dependent on
the IIS.
Various redox and molecular pathways
SKN-1 pathway has been linked with downregulation of
proteasome function. More speciﬁcally, under normal conditions,
RNAi of skn-1 in worms slightly decreases the expression of certain
proteasome genes such as rpn-2, pas-4 and pbs-6. These results
show the inﬂuence of SKN-1 on proteasome expression that
however is limited under normal conditions. In bright contrast,
as discussed in UPS regulation section, SKN-1 is activated upon
proteasome perturbation to cope for the lost expression of various
proteasome genes [19,75,119,122]. Li and colleagues [97] have
revealed that SKN-1 activity is also induced upon inhibition of
translation initiation or elongation. More speciﬁcally, they showed
that impairment of translation elongation results to reduced UPS
activity in the intestine, thus linking protein synthesis and
degradation. A previous work had already identiﬁed several genes
involved in protein folding or degradation, translation elongation
(TEFs) and initiation (TIFs) factors that upon RNAi, a SKN-1-
dependent transcriptional response was initiated, thus promoting
stress resistance and lifespan [177].
The lysosome-mediated proteolysis is the other major proteo-
lytic pathway of the cell. BEC-1 is a protein responsible for the
formation of autophagosomes. Impairement of bec-1 through RNAi
in C. elegans leads to proteasome activation. Additionally, in mev-1
mutants (mev-1 is a gene that encodes for a component of
complex II; the succinate dehydrogenase cytochrome b), that have
been subjected to bec-1 RNAi, no further reduction in their lifespan
was reported, in contrast to mev-1 mutants that have been
subjected to RNAi for both bec-1 and ubq-1 (a major protein of
the UPS pathway) and have been found to have a reduced lifespan.
These results indicate that BEC-1 negatively regulates the protea-
some activity [37].
O-GlcNAcylation is a post-translational modiﬁcation that occurs
in the brain tissue cells and is involved in several neurodegenerative
diseases. Wang and colleagues [178] used mutant strains of C. elegans
that expressed null alleles of the enzymes of O-GlcNAc cycling and
concluded that O-GlcNAcylation downregulates proteasome function
through a DAF-16-dependent mechanism.
Polyglutamine expansion (polyQs) plays a key role in many
age-related neurodegenerative diseases. Polyglutamine expansion
has been detected in proteins such ataxin-3 and huntingtin.
These proteins form inclusions in the nucleus or the cytoplasm
in neuronal cells and as they aggregate, they induce neuronal
toxicity, thus leading to the activation of protective mechanisms.
Expanded polyQs cause the impairment of the ubiquitin-mediated
proteasomal function [80]. More speciﬁcally, ataxin-3 (ΑΤΧ-3) is a
polyQ protein that as mentioned above is involved in Machado-
Joseph disease. AΤΧ-3 binds tο ubiquitin molecules, NEDD8 (an
ubiquitin-like molecule) and ubiquitinated proteins and acts as a
deubiquitylating enzyme (DUB) cleaving off the chains of ubiquitin
from the protein substrates. Mutant worms that overexpress atx-3
exhibit lower rates of proteasome-mediated degradation through
a DAF-16-dependent mechanism [138,36].
Chemical or natural compounds
Acetylcholine (Ach) is an organic molecule that acts as a
neurotransmitter through synapses and levamisole is a synthetic
agonist of acetylcholine. Treatment of worms with one of these
molecules causes inhibition of proteasome-mediated proteolysis
[94] and negatively regulates the proteasome-mediated degrada-
tion of various muscle proteins [165]. Calcium is another molecule
that has been implicated to proteasome regulation. More speciﬁ-
cally, RNAi screening for several genes that are responsible for the
regulation of muscle protein degradation in C. elegans revealed
that calcium is a negative regulator of the proteasome and a
positive regulator of autophagy [151].
Conclusions
Protein degradation is implicated in normal function/physiology
of cells and consequently in organismal homeostasis. Defective
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function results in increased pathophysiology that can lead to
various diseases and even death. Since life is tightly linked to redox
regulation, it is not bizarre that the UPS system is equally subjected
to redox-mediated regulation. It is of immense importance to
identify all the possible negative or positive regulators of the UPS
system since proteolysis modulation is a promising area in the
battle against different conditions/diseases where up- or down-
regulation of the system occurs. For example, proteolysis activation
is desirable during the progression of ageing [20,21] or the
progression of neurodegenerative diseases ([14]) where UPS is
found downregulated or inhibited. On the opposite side, proteolysis
inhibition is also needed in situations of hyperactivation of the UPS
like in various cancers. The model organism C. elegans seems to be a
nice tool in the identiﬁcation of UPS modulators. Several UPS-
related proteins that have been identiﬁed so far to alter the
proteasome function in the worms have also been shown to exert
a similar role in human cells (e.g. UBH-4, AIP-1 etc; see above).
Moreover, given that genetic manipulation is rather easy in this
organism while there are several strains that can serve as models
for various diseases (e.g. neurodegenerative diseases), the value of
this model to study redox regulation of the UPS is undeniable.
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